Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Osteoporosis | Research

Age-adjusted Charlson comorbidity index is associated with the risk of osteoporosis in older fall-prone men: a retrospective cohort study

Authors: Zi-Mo Pan, Jing Zeng, Ting Li, Fan Hu, Xiao-Yan Cai, Xin-Jiang Wang, Guan-Zhong Liu, Xing-He Hu, Xue Yang, Yan-Hui Lu, Min-Yan Liu, Yan-Ping Gong, Miao Liu, Nan Li, Chun-Lin Li

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

There is growing evidence linking the age-adjusted Charlson comorbidity index (aCCI), an assessment tool for multimorbidity, to fragility fracture and fracture-related postoperative complications. However, the role of multimorbidity in osteoporosis has not yet been thoroughly evaluated. We aimed to investigate the association between aCCI and the risk of osteoporosis in older adults at moderate to high risk of falling.

Methods

A total of 947 men were included from January 2015 to August 2022 in a hospital in Beijing, China. The aCCI was calculated by counting age and each comorbidity according to their weighted scores, and the participants were stratified into two groups by aCCI: low (aCCI < 5), and high (aCCI ≥5). The Kaplan Meier method was used to assess the cumulative incidence of osteoporosis by different levels of aCCI. The Cox proportional hazards regression model was used to estimate the association of aCCI with the risk of osteoporosis. Receiver operating characteristic (ROC) curve was adapted to assess the performance for aCCI in osteoporosis screening.

Results

At baseline, the mean age of all patients was 75.7 years, the mean BMI was 24.8 kg/m2, and 531 (56.1%) patients had high aCCI while 416 (43.9%) were having low aCCI. During a median follow-up of 6.6 years, 296 participants developed osteoporosis. Kaplan–Meier survival curves showed that participants with high aCCI had significantly higher cumulative incidence of osteoporosis compared with those had low aCCI (log-rank test: < 0.001). When aCCI was examined as a continuous variable, the multivariable-adjusted model showed that the osteoporosis risk increased by 12.1% (HR = 1.121, 95% CI 1.041–1.206, P = 0.002) as aCCI increased by one unit. When aCCI was changed to a categorical variable, the multivariable-adjusted hazard ratios associated with different levels of aCCI [low (reference group) and high] were 1.00 and 1.557 (95% CI 1.223–1.983) for osteoporosis (P <  0.001), respectively. The aCCI (cutoff ≥5) revealed an area under ROC curve (AUC) of 0.566 (95%CI 0.527–0.605, P = 0.001) in identifying osteoporosis in older fall-prone men, with sensitivity of 64.9% and specificity of 47.9%.

Conclusions

The current study indicated an association of higher aCCI with an increased risk of osteoporosis among older fall-prone men, supporting the possibility of aCCI as a marker of long-term skeletal-related adverse clinical outcomes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Macdonald HM, Nishiyama KK, Kang J, Hanley DA, Boyd SK. Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study. J Bone Miner Res. 2011;26(1):50–62.PubMedCrossRef Macdonald HM, Nishiyama KK, Kang J, Hanley DA, Boyd SK. Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study. J Bone Miner Res. 2011;26(1):50–62.PubMedCrossRef
3.
go back to reference Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21(1):124–31.PubMedCrossRef Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21(1):124–31.PubMedCrossRef
4.
go back to reference Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1). Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1).
5.
go back to reference Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59.PubMedPubMedCentralCrossRef Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59.PubMedPubMedCentralCrossRef
6.
go back to reference Chang KP, Center JR, Nguyen TV, Eisman JA. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo osteoporosis epidemiology study. J Bone Miner Res. 2004;19(4):532–6.PubMedCrossRef Chang KP, Center JR, Nguyen TV, Eisman JA. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo osteoporosis epidemiology study. J Bone Miner Res. 2004;19(4):532–6.PubMedCrossRef
7.
go back to reference Jarvinen TL, Sievanen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336(7636):124–6.PubMedPubMedCentralCrossRef Jarvinen TL, Sievanen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336(7636):124–6.PubMedPubMedCentralCrossRef
8.
go back to reference Lewis SR, McGarrigle L, Pritchard MW, Bosco A, Yang Y, Gluchowski A, et al. Population-based interventions for preventing falls and fall-related injuries in older people. Cochrane Database Syst Rev. 2024;1(1):CD013789.PubMed Lewis SR, McGarrigle L, Pritchard MW, Bosco A, Yang Y, Gluchowski A, et al. Population-based interventions for preventing falls and fall-related injuries in older people. Cochrane Database Syst Rev. 2024;1(1):CD013789.PubMed
9.
go back to reference Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, et al. A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12(8):699–705.PubMedCrossRef Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, et al. A simple tool to identify asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12(8):699–705.PubMedCrossRef
10.
go back to reference Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Investig. 2024;47(3):501–11.CrossRef Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Investig. 2024;47(3):501–11.CrossRef
11.
go back to reference Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.PubMedPubMedCentralCrossRef Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.PubMedPubMedCentralCrossRef
12.
go back to reference Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina AM. Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb. 2019;9:2235042X19870934.PubMedPubMedCentralCrossRef Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina AM. Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb. 2019;9:2235042X19870934.PubMedPubMedCentralCrossRef
13.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRef
14.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.PubMedCrossRef Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.PubMedCrossRef
15.
go back to reference Barcelos A, Lopes DG, Canhao H, da Cunha BJ, Rodrigues AM. Multimorbidity is associated with fragility fractures in women 50 years and older: a nationwide cross-sectional study. Bone Rep. 2021;15:101139.PubMedPubMedCentralCrossRef Barcelos A, Lopes DG, Canhao H, da Cunha BJ, Rodrigues AM. Multimorbidity is associated with fragility fractures in women 50 years and older: a nationwide cross-sectional study. Bone Rep. 2021;15:101139.PubMedPubMedCentralCrossRef
16.
go back to reference Clausen A, Moller S, Skjodt MK, Bech BH, Rubin KH. Evaluating the performance of the Charlson comorbidity index (CCI) in fracture risk prediction and developing a new Charlson fracture index (CFI): a register-based cohort study. Osteoporos Int. 2022;33(3):549–61.PubMedCrossRef Clausen A, Moller S, Skjodt MK, Bech BH, Rubin KH. Evaluating the performance of the Charlson comorbidity index (CCI) in fracture risk prediction and developing a new Charlson fracture index (CFI): a register-based cohort study. Osteoporos Int. 2022;33(3):549–61.PubMedCrossRef
17.
go back to reference Hasan O, Barkat R, Rabbani A, Rabbani U, Mahmood F, Noordin S. Charlson comorbidity index predicts postoperative complications in surgically treated hip fracture patients in a tertiary care hospital: retrospective cohort of 1045 patients. Int J Surg. 2020;82:116–20.PubMedCrossRef Hasan O, Barkat R, Rabbani A, Rabbani U, Mahmood F, Noordin S. Charlson comorbidity index predicts postoperative complications in surgically treated hip fracture patients in a tertiary care hospital: retrospective cohort of 1045 patients. Int J Surg. 2020;82:116–20.PubMedCrossRef
18.
go back to reference Wong RMY, Zu Y, Chau WW, Tso CY, Liu WH, Ng RWK, et al. High Charlson comorbidity index score is associated with early fracture-related complication for internal fixation of neck of femur fractures. Sci Rep. 2022;12(1):4749.PubMedPubMedCentralCrossRef Wong RMY, Zu Y, Chau WW, Tso CY, Liu WH, Ng RWK, et al. High Charlson comorbidity index score is associated with early fracture-related complication for internal fixation of neck of femur fractures. Sci Rep. 2022;12(1):4749.PubMedPubMedCentralCrossRef
19.
go back to reference Puth MT, Klaschik M, Schmid M, Weckbecker K, Munster E. Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord. 2018;19(1):144.PubMedPubMedCentralCrossRef Puth MT, Klaschik M, Schmid M, Weckbecker K, Munster E. Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord. 2018;19(1):144.PubMedPubMedCentralCrossRef
20.
go back to reference Morse JM, Black C, Oberle K, Donahue P. A prospective study to identify the fall-prone patient. Soc Sci Med. 1989;28(1):81–6.PubMedCrossRef Morse JM, Black C, Oberle K, Donahue P. A prospective study to identify the fall-prone patient. Soc Sci Med. 1989;28(1):81–6.PubMedCrossRef
22.
go back to reference Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39–43.PubMedCrossRef Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39–43.PubMedCrossRef
23.
go back to reference Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12(1):16–23.PubMedCrossRef Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12(1):16–23.PubMedCrossRef
24.
go back to reference Zysset P, Qin L, Lang T, Khosla S, Leslie WD, Shepherd JA, et al. Clinical use of quantitative computed tomography-based finite element analysis of the hip and spine in the Management of Osteoporosis in adults: the 2015 ISCD official positions-part II. J Clin Densitom. 2015;18(3):359–92.PubMedCrossRef Zysset P, Qin L, Lang T, Khosla S, Leslie WD, Shepherd JA, et al. Clinical use of quantitative computed tomography-based finite element analysis of the hip and spine in the Management of Osteoporosis in adults: the 2015 ISCD official positions-part II. J Clin Densitom. 2015;18(3):359–92.PubMedCrossRef
25.
go back to reference Takada Y, Kawashima H, Ohno E, Ishikawa T, Mizutani Y, Iida T, et al. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors. J Gastroenterol. 2022;57(3):199–207.PubMedCrossRef Takada Y, Kawashima H, Ohno E, Ishikawa T, Mizutani Y, Iida T, et al. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors. J Gastroenterol. 2022;57(3):199–207.PubMedCrossRef
26.
go back to reference Petermann-Rocha F, Ferguson LD, Gray SR, Rodriguez-Gomez I, Sattar N, Siebert S, et al. Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants. J Cachexia Sarcopenia Muscle. 2021;12(5):1179–88.PubMedPubMedCentralCrossRef Petermann-Rocha F, Ferguson LD, Gray SR, Rodriguez-Gomez I, Sattar N, Siebert S, et al. Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants. J Cachexia Sarcopenia Muscle. 2021;12(5):1179–88.PubMedPubMedCentralCrossRef
27.
go back to reference Gourlay ML, Overman RA, Fine JP, Filteau G, Cawthon PM, Schousboe JT, et al. Time to osteoporosis and major fracture in older men: the MrOS study. Am J Prev Med. 2016;50(6):727–36.PubMedPubMedCentralCrossRef Gourlay ML, Overman RA, Fine JP, Filteau G, Cawthon PM, Schousboe JT, et al. Time to osteoporosis and major fracture in older men: the MrOS study. Am J Prev Med. 2016;50(6):727–36.PubMedPubMedCentralCrossRef
28.
go back to reference Newton PJ, Si S, Reid CM, Davidson PM, Hayward CS, Macdonald PS, et al. Survival after an acute heart failure admission. Twelve-month outcomes from the NSW HF snapshot study. Heart Lung Circ. 2020;29(7):1032–8.PubMedCrossRef Newton PJ, Si S, Reid CM, Davidson PM, Hayward CS, Macdonald PS, et al. Survival after an acute heart failure admission. Twelve-month outcomes from the NSW HF snapshot study. Heart Lung Circ. 2020;29(7):1032–8.PubMedCrossRef
29.
go back to reference Konig S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, et al. In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. Eur Heart J. 2018;39(44):3947–57.PubMedCrossRef Konig S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, et al. In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. Eur Heart J. 2018;39(44):3947–57.PubMedCrossRef
30.
go back to reference Erickson SR, Cole E, Kline-Rogers E, Eagle KA. The addition of the Charlson comorbidity index to the GRACE risk prediction index improves prediction of outcomes in acute coronary syndrome. Popul Health Manag. 2014;17(1):54–9.PubMedCrossRef Erickson SR, Cole E, Kline-Rogers E, Eagle KA. The addition of the Charlson comorbidity index to the GRACE risk prediction index improves prediction of outcomes in acute coronary syndrome. Popul Health Manag. 2014;17(1):54–9.PubMedCrossRef
31.
go back to reference Hall RE, Porter J, Quan H, Reeves MJ. Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies. BMC Health Serv Res. 2019;19(1):930.PubMedPubMedCentralCrossRef Hall RE, Porter J, Quan H, Reeves MJ. Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies. BMC Health Serv Res. 2019;19(1):930.PubMedPubMedCentralCrossRef
32.
go back to reference Liljehult J, Christensen T, Christensen KB. Early prediction of one-year mortality in ischemic and Haemorrhagic stroke. J Stroke Cerebrovasc Dis. 2020;29(4):104667.PubMedCrossRef Liljehult J, Christensen T, Christensen KB. Early prediction of one-year mortality in ischemic and Haemorrhagic stroke. J Stroke Cerebrovasc Dis. 2020;29(4):104667.PubMedCrossRef
33.
go back to reference Esteban C, Garcia-Gutierrez S, Legarreta MJ, Anton-Ladislao A, Gonzalez N, Lafuente I, et al. One-year mortality in COPD after an exacerbation: the effect of physical activity changes during the event. COPD. 2016;13(6):718–25.PubMedCrossRef Esteban C, Garcia-Gutierrez S, Legarreta MJ, Anton-Ladislao A, Gonzalez N, Lafuente I, et al. One-year mortality in COPD after an exacerbation: the effect of physical activity changes during the event. COPD. 2016;13(6):718–25.PubMedCrossRef
34.
go back to reference van de Vorst IE, Goluke NMS, Vaartjes I, Bots ML, Koek HL. A prediction model for one- and three-year mortality in dementia: results from a nationwide hospital-based cohort of 50,993 patients in the Netherlands. Age Ageing. 2020;49(3):361–7.PubMedPubMedCentralCrossRef van de Vorst IE, Goluke NMS, Vaartjes I, Bots ML, Koek HL. A prediction model for one- and three-year mortality in dementia: results from a nationwide hospital-based cohort of 50,993 patients in the Netherlands. Age Ageing. 2020;49(3):361–7.PubMedPubMedCentralCrossRef
35.
go back to reference Pares-Badell O, Banque M, Macia F, Castells X, Sala M. Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol. 2017;49:66–74.PubMedCrossRef Pares-Badell O, Banque M, Macia F, Castells X, Sala M. Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol. 2017;49:66–74.PubMedCrossRef
36.
go back to reference Matthes KL, Limam M, Pestoni G, Held L, Korol D, Rohrmann S. Impact of comorbidities at diagnosis on prostate cancer treatment and survival. J Cancer Res Clin Oncol. 2018;144(4):707–15.PubMedCrossRef Matthes KL, Limam M, Pestoni G, Held L, Korol D, Rohrmann S. Impact of comorbidities at diagnosis on prostate cancer treatment and survival. J Cancer Res Clin Oncol. 2018;144(4):707–15.PubMedCrossRef
37.
go back to reference Chang HT, Shi HY, Wang BW, Yeh SJ. Breast Cancer incidence and predictors of surgical outcome: a Nationwide longitudinal study in Taiwan. Clin Oncol (R Coll Radiol). 2017;29(6):362–9.PubMedCrossRef Chang HT, Shi HY, Wang BW, Yeh SJ. Breast Cancer incidence and predictors of surgical outcome: a Nationwide longitudinal study in Taiwan. Clin Oncol (R Coll Radiol). 2017;29(6):362–9.PubMedCrossRef
38.
go back to reference Holler JG, Eriksson R, Jensen TO, van Wijhe M, Fischer TK, Sogaard OS, et al. First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study. BMC Infect Dis. 2021;21(1):39.PubMedPubMedCentralCrossRef Holler JG, Eriksson R, Jensen TO, van Wijhe M, Fischer TK, Sogaard OS, et al. First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study. BMC Infect Dis. 2021;21(1):39.PubMedPubMedCentralCrossRef
39.
go back to reference Gopaldas RR, Chu D, Dao TK, Huh J, Lemaire SA, Coselli JS, et al. Predictors of surgical mortality and discharge status after coronary artery bypass grafting in patients 80 years and older. Am J Surg. 2009;198(5):633–8.PubMedCrossRef Gopaldas RR, Chu D, Dao TK, Huh J, Lemaire SA, Coselli JS, et al. Predictors of surgical mortality and discharge status after coronary artery bypass grafting in patients 80 years and older. Am J Surg. 2009;198(5):633–8.PubMedCrossRef
40.
go back to reference Moodley Y. Outcome-specific Charlson comorbidity indices for predicting poor inpatient outcomes following noncardiac surgery using hospital administrative data. Med Care. 2016;54(12):1082–8.PubMedCrossRef Moodley Y. Outcome-specific Charlson comorbidity indices for predicting poor inpatient outcomes following noncardiac surgery using hospital administrative data. Med Care. 2016;54(12):1082–8.PubMedCrossRef
41.
go back to reference Khan SA, Shields S, Abusamaan MS, Mathioudakis N. Association between dysglycemia and the Charlson comorbidity index among hospitalized patients with diabetes. J Diabetes Complicat. 2022;36(10):108305.CrossRef Khan SA, Shields S, Abusamaan MS, Mathioudakis N. Association between dysglycemia and the Charlson comorbidity index among hospitalized patients with diabetes. J Diabetes Complicat. 2022;36(10):108305.CrossRef
42.
go back to reference Kubo Y, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, et al. Influences of the Charlson comorbidity index and nutrition status on prognosis after esophageal Cancer surgery. Ann Surg Oncol. 2021;28(12):7173–82.PubMedCrossRef Kubo Y, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, et al. Influences of the Charlson comorbidity index and nutrition status on prognosis after esophageal Cancer surgery. Ann Surg Oncol. 2021;28(12):7173–82.PubMedCrossRef
43.
go back to reference Qu WF, Zhou PY, Liu WR, Tian MX, Jin L, Jiang XF, et al. Age-adjusted Charlson comorbidity index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection. Ann Transl Med. 2020;8(7):487.PubMedPubMedCentralCrossRef Qu WF, Zhou PY, Liu WR, Tian MX, Jin L, Jiang XF, et al. Age-adjusted Charlson comorbidity index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection. Ann Transl Med. 2020;8(7):487.PubMedPubMedCentralCrossRef
44.
go back to reference Aoyama T, Yamamoto N, Kamiya M, Murakawa M, Tamagawa H, Sawazaki S, et al. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy. J Cancer Res Ther. 2020;16:S116–21.PubMedCrossRef Aoyama T, Yamamoto N, Kamiya M, Murakawa M, Tamagawa H, Sawazaki S, et al. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy. J Cancer Res Ther. 2020;16:S116–21.PubMedCrossRef
46.
go back to reference Chandra A, Rajawat J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int J Mol Sci. 2021;22(7). Chandra A, Rajawat J. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int J Mol Sci. 2021;22(7).
47.
go back to reference Murray CE, Coleman CM. Impact of diabetes mellitus on bone health. Int J Mol Sci. 2019;20(19). Murray CE, Coleman CM. Impact of diabetes mellitus on bone health. Int J Mol Sci. 2019;20(19).
48.
go back to reference Cannata-Andia JB, Martin-Carro B, Martin-Virgala J, Rodriguez-Carrio J, Bande-Fernandez JJ, Alonso-Montes C, et al. Chronic kidney disease-mineral and bone disorders: pathogenesis and management. Calcif Tissue Int. 2021;108(4):410–22.PubMedCrossRef Cannata-Andia JB, Martin-Carro B, Martin-Virgala J, Rodriguez-Carrio J, Bande-Fernandez JJ, Alonso-Montes C, et al. Chronic kidney disease-mineral and bone disorders: pathogenesis and management. Calcif Tissue Int. 2021;108(4):410–22.PubMedCrossRef
49.
go back to reference Tong X, Chen X, Zhang S, Huang M, Shen X, Xu J, et al. The effect of exercise on the prevention of osteoporosis and bone angiogenesis. Biomed Res Int. 2019;2019:8171897.PubMedPubMedCentralCrossRef Tong X, Chen X, Zhang S, Huang M, Shen X, Xu J, et al. The effect of exercise on the prevention of osteoporosis and bone angiogenesis. Biomed Res Int. 2019;2019:8171897.PubMedPubMedCentralCrossRef
50.
go back to reference Gosch M, Jeske M, Kammerlander C, Roth T. Osteoporosis and polypharmacy. Z Gerontol Geriatr. 2012;45(6):450–4.PubMedCrossRef Gosch M, Jeske M, Kammerlander C, Roth T. Osteoporosis and polypharmacy. Z Gerontol Geriatr. 2012;45(6):450–4.PubMedCrossRef
51.
go back to reference Pickhardt PJ, Lauder T, Pooler BD, Munoz Del Rio A, Rosas H, Bruce RJ, et al. Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening. Osteoporos Int. 2016;27(1):147–52.PubMedCrossRef Pickhardt PJ, Lauder T, Pooler BD, Munoz Del Rio A, Rosas H, Bruce RJ, et al. Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening. Osteoporos Int. 2016;27(1):147–52.PubMedCrossRef
Metadata
Title
Age-adjusted Charlson comorbidity index is associated with the risk of osteoporosis in older fall-prone men: a retrospective cohort study
Authors
Zi-Mo Pan
Jing Zeng
Ting Li
Fan Hu
Xiao-Yan Cai
Xin-Jiang Wang
Guan-Zhong Liu
Xing-He Hu
Xue Yang
Yan-Hui Lu
Min-Yan Liu
Yan-Ping Gong
Miao Liu
Nan Li
Chun-Lin Li
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-05015-z

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine